News | September 02, 2023
Biocon acquires oral solid dosage manufacturing facility of Eywa Pharma for US$7.7 million
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Subscribe To Our Newsletter & Stay Updated
